WORLD

LINK BETWEEN BONE DRUGS AND OESOPHAGEAL CANCER

04.09.2010 [22:05]
Print
A⁺ A^-

Baku, September 4 (AZERTAC). Long-term use of bone-strengthening drugs - used to treat fractures - may boost the risk of oesophageal cancer, Oxford University research suggests, according to BBC News.

The study of 3,000 people found taking bisphosphonates for five years upped the risk from one in 1,000 to two in 1,000 for 60 to 79-year-olds.

The researchers said the risk was small, but reliable information on risks and benefits was needed.

But experts said for many, the case for taking the drugs “would be strong”.

The findings, published in the British Medical Journal, were based on an analysis of anonymised GP records.

They contrast with previous research which found no increased risk for the bone-strengthening drugs.

Other news in this section

12.08.2023 [10:51]

New species of sea monster with 20 arms is found lurking in the frozen seas around Antarctica

16.06.2023 [18:33]

Max Park solves Rubik’s Cube in 3.13 seconds, setting new world record

15.04.2023 [18:19]

Woman spent 500 days alone in a cave for a human experiment

03.04.2023 [18:22]

Mobile phone inventor made first call 50 years ago

05.01.2023 [17:46]

Tokyo's Toyosu market holds first auction in 2023

09.12.2022 [11:53]

Yusaku Maezawa picks K-pop star TOP and DJ Steve Aoki to join SpaceX moon trip

25.07.2022 [12:18]

Companies 'visualize' sound to help the hearing impaired

20.05.2022 [15:10]

Vintage Mercedes fetches record €135 mn at auction

21.04.2022 [18:48]

LINK BETWEEN BONE DRUGS AND OESOPHAGEAL CANCER

FEEDBACK

Other news in this section